MicroMass, a full-service health communications agency, and part of Ashfield Health, is proud to welcome Noah Lowenthal as Executive Creative Director. In this role, Lowenthal is responsible for defining and driving the creative vision and strategy for the agency. He will help evolve and elevate the agency’s creative services, drawing on over 20 years of experience leading in the creation of award-winning solutions and campaigns. Noah previously served as Senior VP/Group Creative Director and shareholder at AbelsonTaylor, a Chicago-based health and wellness agency.
MicroMass launched Human Dynamics in June. This proprietary methodology helps pharmaceutical brands connect with patients and create a better experience.
“There is so much talk across the industry about data and insights, but very little clear purpose or creative methodology on how to turn that information into creative that uniquely and reliably drives action,” said Noah Lowenthal. “The MicroMass behavioral science approach, when combined with an emphasis on experience design, is what allows us to not just see the human beneath the research, but to then move them, as a patient, to take action.”
Noah will serve on MicroMass’ executive team, alongside Roseanne Johnson (President), Phil Stein (CEO), Rob Peters (EVP, Strategy), and John Hamilton (EVP, Business Development).
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.